KNOWLEDGE HUB
Tackling Obesity
Insights on a pervasive global health challenge
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESObesity is a pervasive global health challenge transcending border and, impacting millions with profound consequences to their well-being and quality of life.
Obesity prevalence could increase dramatically by 2035, to an approximately 25% of the global population classed as obese. This would mean a dramatically escalating burden on healthcare systems worldwide, fostering the rise of cardiovascular risk factors, and chronic conditions including diabetes, kidney and liver diseases. This is why there is so much interest in new obesity pharmacotherapies, with a rich pipeline of new agents, injectable and oral with a wide range of mechanisms of action from both large and emerging pharmaceutical companies.
IQVIA works with policy makers, healthcare systems, payers, pharmaceutical companies and researchers to tackle the obesity epidemic, identifying key trends, researching strategies and developing thought leadership to move forward, as well as providing solutions ranging from clinical research, real world data, market access and healthcare system capacity development, commercialisation and monitoring
Innovators must seek patient-relevant differentiation beyond weight loss. Read article
The innovation landscape, opportunities, challenges and public health potential. Read full article
More segmented and reflective of diverse patient needs. Read full article
What’s different is that we are seeing the birth of a major new market for effective prescription medications. Read full article
The veil has finally been lifted from the landmark SELECT cardiovascular outcomes trial. Read full article
The readout of the Wegovy SELECT cardiovascular outcomes trial marks a moment of truth for the future of the obesity market – and SELECT did deliver. Read full article
2023 brought a step-change in the treatment paradigm for obesity, bringing the obesity market on the edge of a major inflection point.
Each blog of this series dives into the latest the latest trends in cardiometabolic breakthrough innovation, the market opportunity, and critical success factors for innovators, providing you with a fresh and timely perspective on the ever-changing market landscape.